Evolus (EOLS) Invested Capital (2018 - 2025)
Evolus' (EOLS) quarterly Invested Capital came in at $33.1 million in Q1 2025, down 6.55% YoY from $35.4 million in Q1 2024, and down 1.4% on a QoQ basis from $33.6 million in Q4 2024.
Evolus (EOLS) Invested Capital (2018 - 2025) Analysis & Trends
Evolus (EOLS) has 8 years of Invested Capital data on file, last reported at $33.1 million in Q1 2025.
- Quarterly Invested Capital fell 6.55% year-over-year to $33.1 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $33.1 million (down 76.06% YoY) and the FY2024 annual result came in at $33.6 million, down 7.32% from the prior year.
- Invested Capital slipped to $33.1 million in Q1 2025, from $33.6 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $39.8 million in Q4 2022 to a low of $33.1 million in Q1 2025.
- A 5-year average of $37.5 million and a median of $38.7 million in 2021 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2021 — Invested Capital rose 23.81% — and 2024, when it dropped 11.51%.
- Tracing EOLS's Invested Capital over 5 years: stood at $39.4 million in 2021, then climbed by 1.08% to $39.8 million in 2022, then slipped by 9.16% to $36.2 million in 2023, then fell by 7.32% to $33.6 million in 2024, then decreased by 1.4% to $33.1 million in 2025.
- The last three Invested Capital figures came in at $33.1 million (Q1 2025), $33.6 million (Q4 2024), and $34.6 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Evolus | 550.51 Mn | 505.34 Mn | 57.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 33.08 Mn |
| Dec 31, 2024 | 33.55 Mn |
| Sep 30, 2024 | 34.60 Mn |
| Jun 30, 2024 | 34.60 Mn |
| Mar 31, 2024 | 35.40 Mn |
| Dec 31, 2023 | 36.20 Mn |
| Sep 30, 2023 | 38.70 Mn |
| Jun 30, 2023 | 39.10 Mn |
| Mar 31, 2023 | 39.60 Mn |
| Dec 31, 2022 | 39.85 Mn |
| Sep 30, 2022 | 39.00 Mn |
| Jun 30, 2022 | 39.20 Mn |
| Mar 31, 2022 | 39.30 Mn |
| Dec 31, 2021 | 39.43 Mn |
| Sep 30, 2021 | 39.00 Mn |
| Jun 30, 2021 | 38.70 Mn |
| Mar 31, 2021 | 38.30 Mn |
| Dec 31, 2020 | 38.10 Mn |
| Sep 30, 2020 | 31.50 Mn |
| Jun 30, 2020 | 35.10 Mn |